InVivoMAb human IgG1 isotype controlIgG isotype control 1 x 1 mg
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0471298
- Awardee
- Bio X Cell
- Contracting organization
- University of Virginia
- Cumulative value
- $178.00
About this award
The University of Virginia awarded contract A207_PO-0471298 to Bio X Cell on August 20, 2026, for the supply of research-grade biological materials. The prime contractor will deliver InVivoMAb human immunoglobulin G1 (IgG1) isotype control antibodies to support the contracting organization's research activities. The single line item specifies delivery of one unit of IgG1 isotype control measuring 1 milligram, with delivery directed to Mary Grachus Harp at the University of Virginia.
The total contract value is $178.00. The award represents a purchase order transaction typical of academic research procurement, wherein the University of Virginia acquired specialized laboratory reagents necessary for immunological research protocols. No additional contract period information or performance schedule details beyond the award date of August 20, 2026, are specified in the available documentation.
Line items
| Item | Total |
|---|---|
| InVivoMAb human IgG1 isotype controlIgG isotype control 1 x 1 mg | $178.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0471298?
Contract A207_PO-0471298 was awarded to Bio X Cell by University of Virginia on August 20, 2026.
How much is contract A207_PO-0471298 worth?
Its cumulative value is $178.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award